Literature DB >> 25062910

Helicase associated 2 domain is essential for helicase activity of RNA helicase A.

Li Xing1, Xia Zhao2, Meijuan Niu2, Lawrence Kleiman3.   

Abstract

RNA helicase A (RHA), a DExD/H box protein, plays critical roles in a wide variety of cellular or viral functions. RHA contains a conserved core helicase domain that is flanked by five other domains. Two double-stranded RNA binding domains (dsRBD1 and dsRBD2) are at the N-terminus, whereas HA2 (helicase associated 2), OB-fold (oligonucleotide- or oligosaccharide-binding fold), and RGG (repeats of arginine and glycine-glycine residues) domains are at the C-terminus. The role of these domains in the helicase activity of RHA is still elusive due to the difficulty of obtaining enzymatically active mutant RHA. Here, we purified a series of mutant RHAs containing deletions in either N-terminus or C-terminus. Analysis of these mutant RHAs reveals that the dsRBDs are not required for RNA unwinding, but can enhance the helicase activity by promoting the binding of RHA to substrate RNA. In contrast, deletion of C-terminal domains including RGG, OB-fold, and HA2 does not significantly affect the binding of RHA to substrate RNA. However, HA2 is essential for the RNA unwinding by RHA whereas the RGG and OB-fold are dispensable. The results indicate that the core helicase domain alone is not enough for RHA to execute the unwinding activity.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Double-stranded RNA binding domain; HA2; OB-fold; RNA binding; RNA helicase A; RNA unwinding

Year:  2014        PMID: 25062910     DOI: 10.1016/j.bbapap.2014.07.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1.

Authors:  Hayriye Verda Erkizan; Jeffrey A Schneider; Kamal Sajwan; Garrett T Graham; Brittany Griffin; Sergey Chasovskikh; Sarah E Youbi; Abraham Kallarakal; Maksymilian Chruszcz; Radhakrishnan Padmanabhan; John L Casey; Aykut Üren; Jeffrey A Toretsky
Journal:  Nucleic Acids Res       Date:  2015-01-06       Impact factor: 16.971

2.  RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors.

Authors:  Parasvi S Patel; Karan Joshua Abraham; Kiran Kumar Naidu Guturi; Marie-Jo Halaby; Zahra Khan; Luis Palomero; Brandon Ho; Shili Duan; Jonathan St-Germain; Arash Algouneh; Francesca Mateo; Samah El Ghamrasni; Haithem Barbour; Daniel R Barnes; Jonathan Beesley; Otto Sanchez; Hal K Berman; Grant W Brown; El Bachir Affar; Georgia Chenevix-Trench; Antonis C Antoniou; Cheryl H Arrowsmith; Brian Raught; Miquel Angel Pujana; Karim Mekhail; Anne Hakem; Razqallah Hakem
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

3.  Identification of RNA helicases in Medicago truncatula and their expression patterns under abiotic stress.

Authors:  Jie Cheng; Songsong Zhou; Kun Yang; Hongyang Yu; Rongrong Chen; Liming Zeng; Hua Li; Yihua Wang; Jianbo Song
Journal:  Physiol Mol Biol Plants       Date:  2021-10-13

Review 4.  RNA Helicase A Regulates the Replication of RNA Viruses.

Authors:  Rui-Zhu Shi; Yuan-Qing Pan; Li Xing
Journal:  Viruses       Date:  2021-02-25       Impact factor: 5.048

5.  Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiency.

Authors:  Sinéad M McGlacken-Byrne; Ignacio Del Valle; Polona Le Quesne Stabej; Laura Bellutti; Luz Garcia-Alonso; Louise A Ocaka; Miho Ishida; Jenifer P Suntharalingham; Andrey Gagunashvili; Olumide K Ogunbiyi; Talisa Mistry; Federica Buonocore; Berta Crespo; Nadjeda Moreno; Paola Niola; Tony Brooks; Caroline E Brain; Mehul T Dattani; Daniel Kelberman; Roser Vento-Tormo; Carlos F Lagos; Gabriel Livera; Gerard S Conway; John C Achermann
Journal:  JCI Insight       Date:  2022-03-08

Review 6.  The biology of DHX9 and its potential as a therapeutic target.

Authors:  Teresa Lee; Jerry Pelletier
Journal:  Oncotarget       Date:  2016-07-05

Review 7.  The RNA helicase A in malignant transformation.

Authors:  Marco Fidaleo; Elisa De Paola; Maria Paola Paronetto
Journal:  Oncotarget       Date:  2016-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.